[1]
|
A. L. Baert and K. Sartor, “Medical Radiology Diagnostic Imaging,” Springer, Heidelberg, 2006.
|
[2]
|
S. A. Eccles, G. Box, W. Court, J. Sandle and C. J. Dean, “Preclinical Models for the Evaluation of Targeted Therapies of Metastatic Disease,” Cell Biophysics, Vol. 24-25, No. 1-3, 1994, pp. 279-291.
|
[3]
|
K. N. Raymond and V. C. Pierre, “Next Generation, High Relaxivity Gadolinium MRI Agents,” Bioconjugate Chemistry, Vol. 16, No. 1, 2005, pp. 3-8.
doi:10.1021/bc049817y
|
[4]
|
C. J. Mettlin, G. P. Murphy, R. Ho and H. R. Menck, “The National Cancer Data Base Report on Longitudinal Observations on Prostate Cancer,” Cancer, Vol. 77, No. 10, 1996, pp. 2162-2166.
doi:10.1002/(SICI)1097-0142(19960515)77:10<2162::AID-CNCR30>3.0.CO;2-R
|
[5]
|
C. Galasko, “The Anatomy and Pathways of Skeletal Metastases,” In: L. Weiss and A. H. Gilbert, Eds., Bone Metastases, G. K. Hall, Boston, 1981, pp. 49-63.
|
[6]
|
M. S. O’Reilly, L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, W. S. Lane, Y. Cao, E. H. Sage and J. Folkman, “Angiostatin: A Novel Angiogenesis Inhibitor That Mediates the Suppression of Metastases by a Lewis Lung Carcinoma,” Cell, Vol. 79, No. 2, 1994, pp. 315-328. doi:10.1016/0092-8674(94)90200-3
|
[7]
|
L. Wang, H. Chen, M. H. Pourgholami, J. Beretov, J. Hao, H. Chao, A. C. Perkins, J. H. Kearsley and L. Yong, “Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites and Prolong Survival in an in Vivo Ovarian Cancer Model,” Plos One, Vol. 6, No. 9, 2011, e24405.
doi:10.1371/journal.pone.0024405
|
[8]
|
D. J. Yang, C. G. Kim, N. R. Schechter, A. Azhdarinia, D. F. Yu, C. S. Oh, J. L. Bryant, E. E. Kim and D. A. Podoloff, “Imaging with 99Tcm-ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents,” Radiology, Vol. 226, 2003, pp. 465-473.
doi:10.1148/radiol.2262011811
|
[9]
|
C. F. Geraldes and S. Laurent, “Classification and Basic Properties of Contrast Agents for Magnetic Resonance Imaging”, Contrast Media and Molecular Imaging, Vol. 4, No. 1, 2009, pp. 1-23. doi:10.1002/cmmi.265
|
[10]
|
I. Haririan, M. S. Alavidjeh, M. R. Khorramizadeh, M. S. Ardestani, Z. Z. Ghane and H. Namazi, “Anionic Linear-Globular Dendrimer-Cis-Platinum (II) Conjugates Promote Cytotoxicity in Vitro against Different Cancer Cell Lines,” International Journal of Nanomedicine, Vol. 5, 2010, pp. 63-75. doi:10.2147/IJN.S8595
|
[11]
|
M. S. Alavidjeh, I. Haririan, M. R. Khorramizadeh, Z. Z. Ghane, M. S. Ardestani and H. Namazi, “Anionic Linear-Globular Dendrimers: Biocompatible Hybrid Materials with Potential Uses in Nanomedicine,” Jopurnal of Material Sciences and Material Medicine, Vol. 21, No. 4, 2010, pp. 1121-1133. doi:10.1007/s10856-009-3978-8
|
[12]
|
M. Amanlou, S. D. Siadat, S. E. S. Ebrahimi, A. Alavi, M. R. Aghasadeghi, M. S Ardestani, S. Shanehsaz, M. Ghorbani, B. Mehravi, M. S. Alavidjeh, A. Jabbari-Arabzadeh and M. Abbasi, “Gd3+-DTPA-DG: Novel Nanosized Dual Anticancer and Molecular Imaging Agent,” International Journal of Nanomedicine, Vol. 6, 2011, pp. 747-763.
doi:10.2147/IJN.S17648
|
[13]
|
D. Shahbazi-Gahrouei, “Novel MR Imaging Contrast Agents for Cancer Detection,” Journal of Research in Medical Sciences, Vol. 14, No. 3, 2009, pp. 141-147.
|
[14]
|
R. Singh and D. Bandyopadhyay, “MUC-1: A Target Molecule for Cancer Therapy,” Cancer Biology and Therapy, Vol. 6, No. 4, 2007, pp. 481-486.
doi:10.4161/cbt.6.4.4201
|
[15]
|
D. Shahbazi-Gahrouei, M. Williams, S. Rizvi and B. J. Allen, “In Vivo Studies of Gd-DTPA-Monoclonal Antibody and Gd-Porphyrins: Potential MR Imaging Contrast Agents for Cancer,” Journal of Magnetic Resonance Imaging, Vol. 14, No. 2, 2001, pp. 169-174.
doi:10.1002/jmri.1168
|
[16]
|
S. M. Cohen, J. D. Xu, E. Radkov, K. N. Raymond, M. Botta, A. Barge and S. Aime, “Syntheses and Relaxation Properties of Mixed Gadolinium Hydroxypyridinonate MRI Contrast Agents,” Inorganic Chemistry, Vol. 39, No. 25, 2000, pp. 5747-5756. doi:10.1021/ic000563b
|
[17]
|
S. H. Koenig and R. D. Brown, “NMR Spectroscopy of Cells and Organism,” CRC Press, Boca Raton, 1987, p. 756.
|
[18]
|
S. Von Mensdorff-Pouilly, M. M. Gouretvich, P. Kenemans, A. A. Verstraeten, G. J. Van Kamp, et al., “An Enzyme-Linked Immunosorbent Assay for the Measurement of Circulating Antibodies to Polymorphic Epithelial Mucin (MUC-1),” Tumor Biology, Vol. 19, No. 3, 1998, pp. 186-195. doi:10.1159/000030006
|
[19]
|
G. Parnaud, S. Tache, G. Peiffer and D. E. Corpet, “Polyethylene-Glycol Suppresses Colon Cancer and Causes Dose-Dependent Regression of Azoxymethane-Induced Aberrant Crypt Foci in Rats,” Cancer Research, Vol. 59, No. 20, 1999, pp. 5143-5147.
|
[20]
|
M. Mirzaei, M. A. Mohagheghi, D. Shahbazi-Gahrouei and A. Khatami, “Novel Nanosized Gd3+-ALGD-G2-C595: In Vivo Dual Selective MUC-1 Positive Tumor Molecular MR Imaging and Therapeutic Agent,” Journal of Nanomedicine and Nanotechnology, Vol. 3, No. 147, 2012, pp. 1000147. doi:10.4172/2157-7439.1000147
|
[21]
|
S. Giray, T. Bal, A. M. Kartal, S. K?z?lel and C. Erkey, “Controlled Drug Delivery through a Novel PEG Hydrogel Encapsulated Silica Aerogel System,” Journal of Biomedical Materials Research A, Vol. 100, No. 5, 2012, pp. 1307-1315. doi:10.1002/jbm.a.34056
|
[22]
|
N. Fischer-Durand, M. Salmain, B. Rudolf, L. Dai, L. Juge, V. Guérineau, O. Laprévote, A. Vessières and G. Jaouen, “Site-Specific Conjugation of Metal Carbonyl Dendrimer to Antibody and Its Use as Detection Reagent in Immunoassay”, Analytical Biochemistry, Vol. 407, No. 2, 2010, pp. 211-219. doi:10.1016/j.ab.2010.08.027
|
[23]
|
P. K. Smith, R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson and D. C. Klenk, “Measurement of Protein Using Bicinchoninic Acid,” Analytical Biochemistry, Vol. 150, No. 1, 1985, pp. 76-85.
doi:10.1016/0003-2697(85)90442-7
|